After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Arrowhead Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc is $2.68B. A total of 3.85 million shares were traded on the day, compared to an average of 1.53M shares.
In the most recent transaction, OLUKOTUN ADEOYE Y bought 959 shares of ARWR for 20.97 per share on Jan 23 ’25. In a previous transaction on Jan 06 ’25, Hamilton James C sold 32,729 shares at 19.82 per share. ARWR shares that Chief Discovery/Trans Medicine owns now total 272,122.
Among the insiders who sold shares, O’Brien Patrick disposed of 29,184 shares on Jan 06 ’25 at a per-share price of $19.82. This resulted in the COO and General Counsel holding 535,201 shares of ARWR after the transaction. In another insider transaction, O’Brien Patrick sold 8,000 shares at $19.69 per share on Jan 07 ’25. Company shares held by the COO and General Counsel now total 527,201.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ARWR has a high of $36.72 and a low of $17.05.
As of this writing, ARWR has an earnings estimate of -$0.72 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $2.91 per share and a lower estimate of -$1.43.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $1.49, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.
